23 May 2013
Keywords: neurosearch, reports, progress, drug, alzheimer, disease, danish
Article | 11 June 2001
Danish biopharmaceutical company NeuroSearch has reported encouragingresults from a Phase II trial of NS2330, a drug for Alzheimer's disease
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 June 2001
12 June 2001
14 June 2001
© 2013 thepharmaletter.com